Literature DB >> 12446257

Cigarette smoking and risk of Hodgkin's disease: a population-based case-control study.

Nathaniel C Briggs1, H Irene Hall, Edward A Brann, Cynthia J Moriarty, Robert S Levine.   

Abstract

Previous reports offer limited support for an association between cigarette smoking and Hodgkin's disease. The authors investigated dose-response effects for smoking in relation to the risk of Hodgkin's disease using data from the Selected Cancers Study. Cases (n = 343) were men aged 32-60 years identified from eight US population-based cancer registries in 1984-1988. Controls (n = 1,910) were men recruited by random digit telephone dialing and frequency matched to cases by age and registry. Conditional logistic regression was used to calculate odds ratios and 95% confidence intervals adjusted for age, registry, race/ethnicity, Jewish upbringing, education, and childhood domicile. Compared with never smokers, current smokers had a significantly increased risk of Hodgkin's disease (odds ratio (OR) = 1.8, 95% confidence interval (CI): 1.3, 2.9). Risks increased linearly (p < 0.001) with increasing packs per day (OR(>or=2) = 2.5, 95% CI: 1.6, 4.0), years (OR(>or=30) = 2.4, 95% CI: 1.5, 3.9), and pack-years (OR(>40) = 2.7, 95% CI: 1.8, 4.3) of smoking. These associations were significant for the nodular sclerosis and mixed cellularity subtypes but were much stronger for mixed cellularity. Stratified analyses by age (<or=42 years, >42 years) and subtype suggested that the effects of smoking are more closely related to histology than age. In contrast to findings from previous studies, these data suggest that smoking is an important preventable risk factor for Hodgkin's disease.

Entities:  

Mesh:

Year:  2002        PMID: 12446257     DOI: 10.1093/aje/kwf143

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  7 in total

Review 1.  Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph).

Authors:  M Kamper-Jørgensen; K Rostgaard; S L Glaser; S H Zahm; W Cozen; K E Smedby; S Sanjosé; E T Chang; T Zheng; C La Vecchia; D Serraino; A Monnereau; E V Kane; L Miligi; P Vineis; J J Spinelli; J R McLaughlin; P Pahwa; J A Dosman; M Vornanen; L Foretova; M Maynadie; A Staines; N Becker; A Nieters; P Brennan; P Boffetta; P Cocco; H Hjalgrim
Journal:  Ann Oncol       Date:  2013-06-19       Impact factor: 32.976

2.  A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma.

Authors:  Wendy Cozen; Ann S Hamilton; Peng Zhao; Muhammad T Salam; Dennis M Deapen; Bharat N Nathwani; Lawrence M Weiss; Thomas M Mack
Journal:  Blood       Date:  2009-09-08       Impact factor: 22.113

3.  Clinical, molecular, and environmental risk factors for hodgkin lymphoma.

Authors:  Alison Maggioncalda; Neha Malik; Pareen Shenoy; Melody Smith; Rajni Sinha; Christopher R Flowers
Journal:  Adv Hematol       Date:  2010-11-29

4.  Tobacco smoking, alcohol drinking and Hodgkin's lymphoma: a European multi-centre case-control study (EPILYMPH).

Authors:  H Besson; P Brennan; N Becker; S De Sanjosé; A Nieters; R Font; M Maynadié; L Foretova; P L Cocco; A Staines; M Vornanen; P Boffetta
Journal:  Br J Cancer       Date:  2006-07-04       Impact factor: 7.640

5.  The dose-response relationship between tobacco smoking and the risk of lymphomas: a case-control study.

Authors:  Martina Taborelli; Maurizio Montella; Massimo Libra; Rosamaria Tedeschi; Anna Crispo; Maria Grimaldi; Luigino Dal Maso; Diego Serraino; Jerry Polesel
Journal:  BMC Cancer       Date:  2017-06-16       Impact factor: 4.430

6.  Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: a retrospective study of 422,010 patients followed for up to 30 years.

Authors:  Louis Jacob; Moritz Freyn; Matthias Kalder; Konstantinos Dinas; Karel Kostev
Journal:  Oncotarget       Date:  2018-04-03

7.  Disparities in the Concentrations of Essential/Toxic Elements in the Blood and Scalp Hair of Lymphoma Patients and Healthy Subjects.

Authors:  Muhammad Abdul Qayyum; Munir H Shah
Journal:  Sci Rep       Date:  2019-10-25       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.